Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w WałbrzychuZ.O.Z.
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 2024filed
- 2023filed
- 2022filed
- 2021filed
- 202029/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs voivodeship
Public procurement
137 tenders recorded as contracting authority: 118 national and 19 EU.
Notices (contracting authority)
| Publication date | Subject | Amount | Type | |
|---|---|---|---|---|
| Oct 14, 2026 | Supply of plasmapheresis kits together with the lease of plasma separators | –– | Contract notice | |
| Aug 13, 2026 | Supply of diagnostic reagents for immunohematological tests using the automated gel microcolumn technique, together with the lease of analysers for 48 months | $385.2K$385,234 | Contract award notice | |
| Aug 6, 2026 | “Supply of single-use blood collection and laboratory testing equipment for a period of 24 months” – 2nd procedure | $87,112$87,112 | Procedure result |
Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Wałbrzychu is the contractor in 6 public sector contracts, worth USD 1.63k in total. They were signed with 2 public buyers. The largest number (3) were signed with Wielospecjalistyczny Szpital - Samodzielny Publiczny Zespół Opieki Zdrowotnej w Zgorzelcu.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 10, 2026 | Screening test for immune antibodies (manual microcolumn method) in the PTA test | $40.79 | Wielospecjalistyczny Zespół Opieki Zdrowotnej Boleslawiec-Zgorzelec | |
| Sep 1, 2026 | Search for phenotyped blood | $36.74 | Wielospecjalistyczny Zespół Opieki Zdrowotnej Boleslawiec-Zgorzelec | |
| Aug 31, 2026 | ABO and Rh typing, with screening tests for irregular antibodies; antibody identification by PTA test using the microcolumn method – 6-cell panel; antibody identification by enzymatic test using the microcolumn method; DAT – column test using monospecific antiglobulin sera; antibody elution by the acid glycine method; determination of Rh phenotype (C,c,E,e); determination of red blood cell phenotype – Rh system; determination of red blood cell phenotype – Kell system; serological crossmatch with 1 donor; serological crossmatch with each subsequent donor; search for phenotyped blood; STAT tests | $914.78 | Wielospecjalistyczny Szpital - Samodzielny Publiczny Zespół Opieki Zdrowotnej w Zgorzelcu |
Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Wałbrzychu has been a party to 3 cases before the National Appeal Chamber (since 2023). In 3 cases it was the contracting authority.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Sep 30, 2024 | Order | Discontinued | Roche Diagnostics Polska spółka z ograniczoną odpowiedzialnością | |
| Nov 28, 2023 | Discontinuation of the appeal proceedings | Discontinued | Prolab sp. z o.o. | |
| Jul 25, 2023 | Appeal | Discontinued | KENDROLAB sp. z o.o. |
Job offers
Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Wałbrzychu currently has 1 active job offer at a public employment office. 1 offer was posted in the last 12 months.
| Position | Gross salary | Added | |
|---|---|---|---|
| Payroll Specialist / Accountant | from 6,400 PLN/month | 27 Oct 2026 |
Beneficial owners
No beneficial owners recorded for the entity Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Wałbrzychu.
Bank accounts
Registered as a VAT taxpayer on 1998-09-15.
- Bank Gospodarstwa Krajowego03 1130 1033 0018 8182 9320 0009
- Bank Gospodarstwa Krajowego14 1130 1033 0018 8182 9320 0005
- Bank Gospodarstwa Krajowego25 1130 1033 0018 8182 9320 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-02-01 | Equipping and modernising the premises of the public blood service unit as necessary measures to prevent, counteract and combat COVID-19 and other infectious diseases | $1.8M$1,751,096 | Infrastructure and Environment Operational Programme 2014-2020 |
FAQ
Last updated: 2026-04-04